Alpha Tau Medical Ltd Cl A DRTS

$14.48 -0.41 (-2.75%)

Valuation

Market cap
1,344,954,000
Revenue TTM
$0
Net income TTM
$-42,630,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.15

Trading

Volume
427,400
Avg volume
553,650
Day's range
$14.40 – $15.02
Shares out
90,326,000
Stochastic %K
17%
Beta
1.22
Analysts
Sell
Price target
$18.00

Price

Company profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors...

Show more

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 3 577 4115
Website
https://www.alphatau.com
Address
Kiryat HaMada St. 5, Jerusalem, Israel

Latest news

Stocktwits

Herbgator Oct 6, 10:48 PM
$DRTS Barclays analysis : https://www.reddit.com/r/DRTS_Stock/s/p5WKb9Sxhx
0 replies
Richland69 Oct 6, 8:58 PM
$DRTS https://www.biotechtv.com/post/barclays-lukas-shumway-september-30-2026
1 replies
kareem1988 Oct 6, 9:27 AM
$DRTS dominates Reddit on Oct. 5 https://247wallst.com/cards/alpha-tau-medical-is-swallowing-the-board-with-267-comments-drts-reddit-radar-01m464f4v5kqvkj9ywycjcg3px
3 replies
Jessypenny Oct 6, 8:24 AM
$DRTS management is in new york today taking 1x1 meetings at the barclays biotech day. funds sit down with the team face to face. this is how institutional interest gets built, quietly, one meeting at a time.
0 replies
dudebob Oct 5, 8:21 PM
For the SPAC investors. Do you invest in the commons or warrants? Just want to gauge the pulse of these communities, so asking for a variety of opinions to help with some investment decisions. Been noticing some pretty wild former-SPAC warrant moves from historical lows… examples: -BRUNW / WLACW ~$0.21 → ~$6.68 final trade (+3,080%+) -OPTXW ~$0.08 → ~$2.31 (+2,780%+) -DRTSW ~$0.14 → ~$4.20 (+2,900%+) -GFUZW / SVACW ~$0.52 → ~$1.32 (+150%+) Note.. BRUNW has since been redeemed and no longer trades. But these are just examples of what has happened with certain SPAC warrants — plenty never see anything close to this and can lose most or all of their value. Another example, with Tom Lee’s pre-deal $FCRS + FCRS/WS (warrants)… is the extra potential upside really worth taking the warrant risk? Or just stick with commons? He hasn’t announced a target, but his SPAC seems interesting as he’s regularly on CNBC. Thoughts from these SPAC winners?: $BRUN $GFUZ $OPTX $DRTS 🤔🧠💭
0 replies
OnlyGB Oct 5, 5:51 PM
$DRTS feels like the last chance to load up before $15 and beyond hits hard and $14 is forever in the rear view mirror. Alpha Tau meeting with massive financial institutions in October. Hang on!
1 replies
SuperGreenToday Oct 5, 5:10 PM
$DRTS Share Price: $14.82 Contract Selected: Feb 19, 2027 $15 Calls Buy Zone: $1.87 – $2.31 Target Zone: $3.21 – $3.93 Potential Upside: 62% ROI Time to Expiration: 136 Days | Updates via https://fxcapta.com/stockinfo/
0 replies
slaughterhouse5 Oct 5, 3:55 PM
$DRTS let’s GO DRTS, breakout to 20, then to 25 this month.
1 replies